image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9416189_pharmaceutics-14-01645-f006_386624.jpg | What is the focal point of this photograph? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386620.jpg | Describe the main subject of this image. | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416189_pharmaceutics-14-01645-f006_386625.jpg | What is the dominant medical problem in this image? | The anti-bacterial efficacy of BSA@Au. (A) Observation of BSA@Au binding with MRSA by NIR-II FL imaging. Tube 1, 2, and 3 contained the BSA@Au solution, MRSA solution, and the mixed suspension of BSA@Au and MRSA, respectively. (B) MRSA bacterial colonies test on LB agar plates after different treatments. (C) Quantifica... |
PMC9416193_nanomaterials-12-02874-f018_386634.jpg | What is the main focus of this visual representation? | (a) SEM image and fiber diameter distribution of PEG prepared by electrospinning. Reproduced with permission from Ref. [95], Copyright 2016 Elsevier B.V. (b) SEM image of co-electrospun junction with GO. (c) SEM image of the cross-section of 3D BPM with GO as the interface layer catalyst. Reprinted (adapted) with permi... |
PMC9416193_nanomaterials-12-02874-f018_386635.jpg | What can you see in this picture? | (a) SEM image and fiber diameter distribution of PEG prepared by electrospinning. Reproduced with permission from Ref. [95], Copyright 2016 Elsevier B.V. (b) SEM image of co-electrospun junction with GO. (c) SEM image of the cross-section of 3D BPM with GO as the interface layer catalyst. Reprinted (adapted) with permi... |
PMC9416203_pharmaceuticals-15-01034-f001_386639.jpg | What stands out most in this visual? | Anatomopathological examination of primary and peritoneal lesions of high-grade serous ovarian carcinoma (HES: Hematein, Eosin, Saffron), and expression of folate receptor alpha (FRα) by immunohistochemistry. (A1): primary cancer × 10/(A2): FRα (75%; 3), (B1): macroscopic peritoneal metastase × 20/(B2): FRα (30%; 3), (... |
PMC9416203_pharmaceuticals-15-01034-f001_386640.jpg | What is being portrayed in this visual content? | Anatomopathological examination of primary and peritoneal lesions of high-grade serous ovarian carcinoma (HES: Hematein, Eosin, Saffron), and expression of folate receptor alpha (FRα) by immunohistochemistry. (A1): primary cancer × 10/(A2): FRα (75%; 3), (B1): macroscopic peritoneal metastase × 20/(B2): FRα (30%; 3), (... |
PMC9416203_pharmaceuticals-15-01034-f001_386641.jpg | What is the focal point of this photograph? | Anatomopathological examination of primary and peritoneal lesions of high-grade serous ovarian carcinoma (HES: Hematein, Eosin, Saffron), and expression of folate receptor alpha (FRα) by immunohistochemistry. (A1): primary cancer × 10/(A2): FRα (75%; 3), (B1): macroscopic peritoneal metastase × 20/(B2): FRα (30%; 3), (... |
PMC9416203_pharmaceuticals-15-01034-f001_386638.jpg | What is the central feature of this picture? | Anatomopathological examination of primary and peritoneal lesions of high-grade serous ovarian carcinoma (HES: Hematein, Eosin, Saffron), and expression of folate receptor alpha (FRα) by immunohistochemistry. (A1): primary cancer × 10/(A2): FRα (75%; 3), (B1): macroscopic peritoneal metastase × 20/(B2): FRα (30%; 3), (... |
PMC9416243_molecules-27-05164-f008_386645.jpg | Can you identify the primary element in this image? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386647.jpg | What stands out most in this visual? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386644.jpg | What stands out most in this visual? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386643.jpg | What is the focal point of this photograph? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386646.jpg | What is the principal component of this image? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386648.jpg | What stands out most in this visual? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416243_molecules-27-05164-f008_386642.jpg | What is the main focus of this visual representation? | Confocal imaging of HEC-1A cells incubated with ESIPT-F for 30 min. (a–d): Confocal imaging of the HEC-1A cells incubated with ESIPT-F and observed at 10 × 10 magnifications, respectively; (e–h): Live-cell imaging of the same HEC-1A cells acquired at 40 × 40 magnifications. HEC-1A cells were incubated in a DMEM medium ... |
PMC9416271_pharmaceutics-14-01685-f010_386653.jpg | What can you see in this picture? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386650.jpg | What does this image primarily show? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386652.jpg | What is the principal component of this image? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386649.jpg | What is the principal component of this image? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386656.jpg | What object or scene is depicted here? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386654.jpg | What is being portrayed in this visual content? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f010_386651.jpg | What's the most prominent thing you notice in this picture? | The HE and Ki67 staining results of the tumor tissues at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386661.jpg | What can you see in this picture? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386669.jpg | What does this image primarily show? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386670.jpg | What is being portrayed in this visual content? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386659.jpg | What is the dominant medical problem in this image? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386662.jpg | Can you identify the primary element in this image? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386675.jpg | What's the most prominent thing you notice in this picture? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386658.jpg | What is the central feature of this picture? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386666.jpg | What does this image primarily show? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386665.jpg | What is being portrayed in this visual content? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386657.jpg | What is the core subject represented in this visual? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386664.jpg | What is shown in this image? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386667.jpg | What's the most prominent thing you notice in this picture? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386673.jpg | What is the principal component of this image? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386660.jpg | What can you see in this picture? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416271_pharmaceutics-14-01685-f011_386672.jpg | What object or scene is depicted here? | The histological characteristics of representative organs at 200× magnification with the optical microscope. (A) control group; (B) Dios-LP group; (C) CHOL-DOX-LP group; (D) Dios-DOX-LP group. |
PMC9416275_polymers-14-03256-f004_386676.jpg | What key item or scene is captured in this photo? | (a). Laser scanning confocal microscopy (Right). (b). SEM images of impact tested specimen showing the crack path [13] Reproduced with permission from MDPI. |
PMC9416301_polymers-14-03245-f003_386681.jpg | What is the central feature of this picture? | Material surface changes of the experimental CFRP composite; magnification 20× (after 9 weeks); (a) reference material before the test; (b) after 9 weeks of exposure to 20% NaCl at 60 °C; (c) after 9 weeks of exposure to 10% NaOH at 60 °C; (d) after 9 weeks of exposure to 15% H2SO4 at 60 °C. |
PMC9416301_polymers-14-03245-f003_386680.jpg | What is the principal component of this image? | Material surface changes of the experimental CFRP composite; magnification 20× (after 9 weeks); (a) reference material before the test; (b) after 9 weeks of exposure to 20% NaCl at 60 °C; (c) after 9 weeks of exposure to 10% NaOH at 60 °C; (d) after 9 weeks of exposure to 15% H2SO4 at 60 °C. |
PMC9416301_polymers-14-03245-f003_386683.jpg | What stands out most in this visual? | Material surface changes of the experimental CFRP composite; magnification 20× (after 9 weeks); (a) reference material before the test; (b) after 9 weeks of exposure to 20% NaCl at 60 °C; (c) after 9 weeks of exposure to 10% NaOH at 60 °C; (d) after 9 weeks of exposure to 15% H2SO4 at 60 °C. |
PMC9416340_microorganisms-10-01571-f007_386715.jpg | What is the central feature of this picture? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386705.jpg | What is the dominant medical problem in this image? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386707.jpg | What is the core subject represented in this visual? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386703.jpg | What key item or scene is captured in this photo? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386708.jpg | What is the main focus of this visual representation? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386714.jpg | What stands out most in this visual? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386711.jpg | What key item or scene is captured in this photo? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386704.jpg | What is the dominant medical problem in this image? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386702.jpg | What is the main focus of this visual representation? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386713.jpg | What is the dominant medical problem in this image? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386700.jpg | What's the most prominent thing you notice in this picture? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386710.jpg | What's the most prominent thing you notice in this picture? | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f007_386709.jpg | Describe the main subject of this image. | Electron micrographs of strains Desmodesmus sp. TAU-MAC 0910 (a–c), Desmodesmus sp. 1817 (d,e), Monoraphidium sp. 1210 (f,g), Uronema trentonense 0215 (h–j), Ava limnothalassea TAU-MAC 2217 (k–m), Nomia picochloropsia TAU-MAC 3617 (n–p); (a): four-celled coenobium with oil bodies and starch grains. (b): spines, ribs, a... |
PMC9416340_microorganisms-10-01571-f008_386698.jpg | What is being portrayed in this visual content? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386696.jpg | What is the dominant medical problem in this image? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386692.jpg | Can you identify the primary element in this image? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386699.jpg | What is the main focus of this visual representation? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386690.jpg | What does this image primarily show? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386691.jpg | Can you identify the primary element in this image? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386693.jpg | What can you see in this picture? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386694.jpg | What is being portrayed in this visual content? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386695.jpg | Describe the main subject of this image. | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416340_microorganisms-10-01571-f008_386697.jpg | What is the principal component of this image? | Electron micrographs of strains Spongiosarcinopsis limneus TAU-MAC 3310 (a,b), Lilaea pamvotia 3510 (c–g), Akraea chliaropsychia 0515 (h–j); (a,b): mature cells with eyespot, and pyrenoid surrounded by starch. (c: mature cell with eyespot. (d): cell with two pyrenoids in the chloroplast. (e): aging cell accumulating st... |
PMC9416342_plants-11-02102-f003_386688.jpg | What is the dominant medical problem in this image? | Observation of the chloroplast ultrastructure between control and MT-treated pakchoi leaves on 0 d (A1,A2), 4 d (B1,B2) and 8 d of shelf life (C1,C2). The red arrows indicate the destruction of chloroplast membranes and the white arrows represent the osmiophilic globules, respectively. |
PMC9416342_plants-11-02102-f003_386687.jpg | What is the core subject represented in this visual? | Observation of the chloroplast ultrastructure between control and MT-treated pakchoi leaves on 0 d (A1,A2), 4 d (B1,B2) and 8 d of shelf life (C1,C2). The red arrows indicate the destruction of chloroplast membranes and the white arrows represent the osmiophilic globules, respectively. |
PMC9416342_plants-11-02102-f003_386684.jpg | What is being portrayed in this visual content? | Observation of the chloroplast ultrastructure between control and MT-treated pakchoi leaves on 0 d (A1,A2), 4 d (B1,B2) and 8 d of shelf life (C1,C2). The red arrows indicate the destruction of chloroplast membranes and the white arrows represent the osmiophilic globules, respectively. |
PMC9416342_plants-11-02102-f003_386686.jpg | Describe the main subject of this image. | Observation of the chloroplast ultrastructure between control and MT-treated pakchoi leaves on 0 d (A1,A2), 4 d (B1,B2) and 8 d of shelf life (C1,C2). The red arrows indicate the destruction of chloroplast membranes and the white arrows represent the osmiophilic globules, respectively. |
PMC9416342_plants-11-02102-f003_386689.jpg | Describe the main subject of this image. | Observation of the chloroplast ultrastructure between control and MT-treated pakchoi leaves on 0 d (A1,A2), 4 d (B1,B2) and 8 d of shelf life (C1,C2). The red arrows indicate the destruction of chloroplast membranes and the white arrows represent the osmiophilic globules, respectively. |
PMC9416346_pharmaceutics-14-01751-f005_386716.jpg | What stands out most in this visual? | Effects of laser-induced lesion (TBI model) on the neuromorphology of the telencephalon one day after the injury in zebrafish. Representative images of brain cryosections of fish from the TBI group stained with hematoxylin and eosin. Black arrows show dilated vessels, white arrows—hemorrhage, yellow arrows—edema. Magni... |
PMC9416346_pharmaceutics-14-01751-f005_386718.jpg | What's the most prominent thing you notice in this picture? | Effects of laser-induced lesion (TBI model) on the neuromorphology of the telencephalon one day after the injury in zebrafish. Representative images of brain cryosections of fish from the TBI group stained with hematoxylin and eosin. Black arrows show dilated vessels, white arrows—hemorrhage, yellow arrows—edema. Magni... |
PMC9416346_pharmaceutics-14-01751-f005_386717.jpg | What can you see in this picture? | Effects of laser-induced lesion (TBI model) on the neuromorphology of the telencephalon one day after the injury in zebrafish. Representative images of brain cryosections of fish from the TBI group stained with hematoxylin and eosin. Black arrows show dilated vessels, white arrows—hemorrhage, yellow arrows—edema. Magni... |
PMC9416348_materials-15-05785-f019_386722.jpg | What stands out most in this visual? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416348_materials-15-05785-f019_386726.jpg | What key item or scene is captured in this photo? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416348_materials-15-05785-f019_386727.jpg | What can you see in this picture? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416348_materials-15-05785-f019_386725.jpg | What stands out most in this visual? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416348_materials-15-05785-f019_386723.jpg | What stands out most in this visual? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416348_materials-15-05785-f019_386729.jpg | What is the principal component of this image? | SEM images of samples with different aging times at 500× and 2000× magnification: (a) 6 h; (b) 12 h; (c) 24 h; (d) 48 h; (e) 72 h; (f) 120 h; (g) 168 h. |
PMC9416361_tomography-08-00163-f003_386731.jpg | What is the core subject represented in this visual? | Newborn male with complex congenital heart disease (double outlet right ventricle, ventricular septal defect, and aortic coarctation) with PALPA. Contrast enhanced axial (A) and (B) axial oblique reconstructed Maximum Intensity Projection (MIP) images from chest CT data demonstrate a duplicated left pulmonary artery wi... |
PMC9416361_tomography-08-00163-f003_386730.jpg | What is being portrayed in this visual content? | Newborn male with complex congenital heart disease (double outlet right ventricle, ventricular septal defect, and aortic coarctation) with PALPA. Contrast enhanced axial (A) and (B) axial oblique reconstructed Maximum Intensity Projection (MIP) images from chest CT data demonstrate a duplicated left pulmonary artery wi... |
PMC9416361_tomography-08-00163-f004_386732.jpg | What object or scene is depicted here? | Incidental finding of PALPA in a 51-year-old male with acute shortness of breath. Contrast enhanced chest CT obtained to rule out pulmonary embolism demonstrates that a duplicated left pulmonary artery with a small left pulmonary artery (thin arrow) to left upper lobe was arising from the main pulmonary artery (bold ar... |
PMC9416361_tomography-08-00163-f004_386733.jpg | What can you see in this picture? | Incidental finding of PALPA in a 51-year-old male with acute shortness of breath. Contrast enhanced chest CT obtained to rule out pulmonary embolism demonstrates that a duplicated left pulmonary artery with a small left pulmonary artery (thin arrow) to left upper lobe was arising from the main pulmonary artery (bold ar... |
PMC9416368_sensors-22-05956-f005_386738.jpg | What is being portrayed in this visual content? | Interferogram, amplitude, and optical images of Jinchuan mining and L’Aquila city. In the Jinchuan mine area, the amplitude image is from the sentinel-1A image on 1 December 2014, the optical image is from google earth’s historical image on 31 December 2014, and the latitude is from 38°27′49″ N to 38°28′58″ N, the long... |
PMC9416368_sensors-22-05956-f005_386737.jpg | What can you see in this picture? | Interferogram, amplitude, and optical images of Jinchuan mining and L’Aquila city. In the Jinchuan mine area, the amplitude image is from the sentinel-1A image on 1 December 2014, the optical image is from google earth’s historical image on 31 December 2014, and the latitude is from 38°27′49″ N to 38°28′58″ N, the long... |
PMC9416388_materials-15-05739-f001_386739.jpg | What is shown in this image? | Photos of CHF under different magnifications. |
PMC9416388_materials-15-05739-f001_386740.jpg | What is the focal point of this photograph? | Photos of CHF under different magnifications. |
PMC9416418_vetsci-09-00400-f003_386742.jpg | What's the most prominent thing you notice in this picture? | Presence of Leishmania amastigotes in macrophages collected through (A) FNA of spleen or (B–D) popliteal lymph node or through (D) swabs from ocular lesions. |
PMC9416418_vetsci-09-00400-f003_386744.jpg | What is the principal component of this image? | Presence of Leishmania amastigotes in macrophages collected through (A) FNA of spleen or (B–D) popliteal lymph node or through (D) swabs from ocular lesions. |
PMC9416418_vetsci-09-00400-f003_386745.jpg | Can you identify the primary element in this image? | Presence of Leishmania amastigotes in macrophages collected through (A) FNA of spleen or (B–D) popliteal lymph node or through (D) swabs from ocular lesions. |
PMC9416434_microorganisms-10-01619-f002_386752.jpg | Can you identify the primary element in this image? | Macroscopic and microscopic images of polystyrene (PS) degradation by Exiguobacterium sp. RIT 594. (a) Macroscopic images of circa 2 × 3 cm pieces cut from PS plates (0.19 mm thickness); top left and bottom left = sterile control; top right and bottom right = incubated in shaking cultures of Exiguobacterium sp. RIT 594... |
PMC9416434_microorganisms-10-01619-f002_386753.jpg | What stands out most in this visual? | Macroscopic and microscopic images of polystyrene (PS) degradation by Exiguobacterium sp. RIT 594. (a) Macroscopic images of circa 2 × 3 cm pieces cut from PS plates (0.19 mm thickness); top left and bottom left = sterile control; top right and bottom right = incubated in shaking cultures of Exiguobacterium sp. RIT 594... |
PMC9416434_microorganisms-10-01619-f002_386748.jpg | What is shown in this image? | Macroscopic and microscopic images of polystyrene (PS) degradation by Exiguobacterium sp. RIT 594. (a) Macroscopic images of circa 2 × 3 cm pieces cut from PS plates (0.19 mm thickness); top left and bottom left = sterile control; top right and bottom right = incubated in shaking cultures of Exiguobacterium sp. RIT 594... |
PMC9416434_microorganisms-10-01619-f004_386755.jpg | What is the dominant medical problem in this image? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386757.jpg | Can you identify the primary element in this image? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386760.jpg | What is the dominant medical problem in this image? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386756.jpg | What is the principal component of this image? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386754.jpg | What is the focal point of this photograph? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386761.jpg | What does this image primarily show? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
PMC9416434_microorganisms-10-01619-f004_386758.jpg | What key item or scene is captured in this photo? | Colonization of different polymers by Exiguobacterium sp. RIT 594. The surfaces of high-density polyethylene (HDPE) (a–d) and of PS (e–h), were recorded following 60 days of shaking in minimal medium (LCFBM) lacking a carbon source other than the polymer. (a) Control without bacterial inoculation (4980× resolution, sca... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.